- Safety and efficacy in actual clinical practice of once-weekly subcutaneous teriparatide for osteoporosis patients with a high fracture risk
-
Ifuku E, Yoshimura , Uzawa T, Hokonohara T
- KMID: 2463605
- Osteoporos Sarcopenia.
- 2019 Jun;5(2):44-50.
- doi: 10.1016/j.afos.2019.06.002
OBJECTIVES: To reassess the safety and efficacy of once-weekly teriparatide 56.5 mg in osteoporosis patients with a high fracture risk. METHODS: This postmarketing observational study was conducted at 72 weeks according... -
- CITED
-
- Close
- SHARE
-
- Close
